Abstracts Archive - Page 408 of 1683 - ATC Abstracts

2020 American Transplant Congress
Deficiencies in Family Planning Counseling and Practices in Kidney Transplant Patients
J. Ritchie¹, D. Seidman², Y. Srisengfa², E. Perito², D. Adey², M. Sarkar²
¹St Luke's University Health Network, Bethlehem, PA, ²UCSF, San Francisco, CA
*Purpose: Nearly 20% of female kidney transplant(KT) recipients are reproductive-aged. Fertility is often impaired pre-transplant, but rapidly restored after KT. Early and unplanned pregnancies after…
2020 American Transplant Congress
Ureteral Complications Post Kidney Transplantation – Incidence and Preferred Treatment Modality
R. Patten¹, H. Mustafa², S. Desai³, J. Buggs⁴, E. Rogers⁴, A. Kumar¹, V. Bowers⁴
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³University of Tampa, Tampa, FL, ⁴Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: The primary objective of this study was to evaluate the incidence of ureteral complications at a single transplant center. A secondary objective was to…
2020 American Transplant Congress
Understanding the Relationship between Health Literacy, Education Level, and Transplant Actions among Low-Income and Black Patients
A. Waterman¹, S. L. Skelton², O. N. Ranasinghe¹, J. L. Beaumont³, L. Alvarez³
¹Transplant Research and Education Center, Los Angeles, CA, ²Southern Illinois University - Edwardsville, Edwardsville, IL, ³Terasaki Research Institute, Los Angeles, CA
*Purpose: Limited health literacy in end stage kidney disease patients is associated with low transplant referral rates. We estimated the prevalence of low health literacy…
2020 American Transplant Congress
Waitlisting for Kidney Transplant and Social Determinants of Health Predict Health-Related Quality of Life (hrqol) in End-Stage Renal Disease (ESRD) Patients
S. L. Swift¹, S. Wang², C. H. Chang³, J. Pleis⁴, M. Dew³, R. Shapiro⁵, M. Unruh¹, K. Kendall⁶, E. Croswell⁷, J. D. Peipert⁸, L. Myaskovsky¹
¹University of New Mexico, Albuquerque, NM, ²University of Florida, Gainsville, FL, ³University of Pittsburg, Pittsburgh, PA, ⁴Centers for Disease Control, Atlanta, GA, ⁵Mount Sinai, New York, NY, ⁶Highmark Health, Pittsburgh, PA, ⁷University of Pittsburgh, Pittsburgh, PA, ⁸Northwestern University, Chicago, IL
*Purpose: Getting waitlisted for a KT has important health implications for patients with ESRD. Less is known about the relationship between waitlisting and subsequent HRQoL…
2020 American Transplant Congress
Recurrence of IgA Nephropathy after Kidney Transplantation – Tango Multicenter Study
A. Uffing¹, P. Cravedi², L. V. Riella¹
¹Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²Icahn School of Medicine at Mount Sinai, New York, NY
*Purpose: In patients with IgA nephropathy as the cause of ESKD, IgA deposits can recur in the transplanted kidney. However,the incidence and clinical impact of…
2020 American Transplant Congress
Determination of Programmed Cell Death Protein 1 (PD1) by Flow Cytometry, a Possible Follow-Up Tool in Renal Transplantation of High Immune Risk
M. Carmona-Escamilla¹, M. Fonseca², J. Prieto Chávez³, L. Arriaga⁴, F. Oviendo⁵, S. , Hernández-Mendoza SA², J. Alberu⁶, G. Queipo²
¹Nephrology, Hospital Central Sur Alta Especialidad "Picacho", CDMX, Mexico, ²Genetics, Hospital General de México Dr. Eduardo Liceaga-Facultad, Ciudad de México, México, CDMX, Mexico, ³Transplant, Hospital General de México Dr. Eduardo Liceaga-Facultad, Ciudad de México, México, CDMX, Mexico, ⁴Unidad de investigación en inmunoqímica,, Hospital de Especialidades Centro Médico Siglo XXI IMSS, CDMX, Mexico, ⁵Unidad de investigación en inmunoqímica,, Hospital de Especialidades Centro Médico Siglo XXI IMSS, Ciudad de México, México, CDMX, Mexico, ⁶Transplant, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, CDMX, Mexico
*Purpose: Introduction: Currently, the follow-up of patients remains to be the serum creatinine level, being highly specific, however, with little sensitivity to determine the occurrence…
2020 American Transplant Congress
Clazakizumab (Anti-IL-6) Induces Foxp3+ Tregs in Highly HLA Sensitized Patients Desensitized for HLAi Transplantation (NCT03380962)
S. C. Jordan, S. Ge, N. Ammerman, M. Toyoda, E. Huang, A. Peng, R. Najjar, S. Sethi, S. Williamson, C. Myers, K. Lim, J. Choi, A. Vo
Cedars Sinai Medical Ctr, West Hollywood, CA
*Purpose: Interleukin-6 is an important inflammatory cytokine. In addition, it acts as a growth factor for B-cells, plasma cells and Th17 cells, inhibiting FoxP3+ Treg…
2020 American Transplant Congress
Operative vs. Non-Operative Management of Hemorrhage in the Postoperative Kidney Transplant Patient
R. Shaw¹, T. Reavis¹, V. Meruva², F. Montz³, E. Rogers⁴, A. Kumar¹, V. Bowers⁴, J. Buggs⁴
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Lake Erie College of Osteopathic Medicine, Bradenton, FL, ³University of Tampa, Tampa, FL, ⁴Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: Postoperative hemorrhage has been described at rates of 14 percent in kidney transplant (KT) literature. The preferred management of postoperative hemorrhage in this population…
2020 American Transplant Congress
Hyperspectral Imaging of Human Kidney Allografts
R. Sucher¹, H. Köhler², A. Lederer¹, H. M. Hau¹, I. Gockel¹, D. Seehofer¹
¹Department of Visceral, Transplant-, Thoracic and Vascular Surgery, University Clinic Leipzig, Leipzig, Germany, ²Innovation Center for Computer Assisted Surgery, University Clinic Leipzig, Leipzig, Germany
*Purpose: Hyperspectral imaging (HSI) is capable to deliver non-contact, non-ionizing and non-invasive quantitative diagnostic information about tissue pathology, morphology and composition, based on the spectral…
2020 American Transplant Congress
Pre- And Post-Transplant (Tx) Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody) Treatment Increased Regulatory T Cell (Treg) Percentage in CD4+ T Cells in HLA-Sensitized Kidney Transplant Patients (HS KTx Pts)
S. Ge¹, M. Chu¹, E. D. Ortiz¹, A. D. Guzman¹, A. Vo², N. Ammerman², S. C. Jordan², M. Toyoda¹
¹Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA, ²Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: IL-6 is a B cell growth factor and pro-inflammatory cytokine. Inhibition of IL-6 signaling modulates B cell activation and inflammatory process possibly through Treg…